Literature DB >> 24999026

Low brain iron effects and reversibility on striatal dopamine dynamics.

Erica L Unger1, Laura E Bianco1, Byron C Jones2, Richard P Allen3, Christopher J Earley4.   

Abstract

Iron deficiency (ID) in rodents leads to decreased ventral midbrain (VMB) iron concentrations and to changes in the dopamine (DA) system that mimic many of the dopaminergic changes seen in RLS patient where low substantia nigra iron is a known pathology of the disease. The ID-rodent model, therefore, has been used to explore the effects that low VMB iron can have on striatal DA dynamics with the hopes of better understanding the nature of iron-dopamine interaction in Restless Legs Syndrome (RLS). Using a post-weaning, diet-induced, ID condition in rats, the No-Net-Flux microdialysis technique was used to examine the effect of ID on striatal DA dynamics and it reversibility with acute infusion of physiological concentrations of iron into the VMB. This study replicated prior findings by showing that the ID condition is associated with increased extracellular striatal DA, reduced striatal DA uptake, and blunted DA-2-receptor-agonist feedback enhancement of striatal DA uptake. Despite the increase in extracellular striatal DA, intracellular striatal DA, as determined in tissue homogenates, was decrease in the ID rat. The study's key finding was that an infusion of physiological concentrations of iron into the VMB reversed the ID-induced increase in extracellular striatal DA and the ID-induced decrease in intracellular striatal DA but had no effect on the ID-induced changes in DA uptake or on the blunted DA-uptake response to quinpirole. In summary, the ID-rodent model provides highly reproducible changes in striatal DA dynamics that remarkably parallel dopaminergic changes seen in RLS patients. Some but not all of these ID-induced changes in striatal DA dynamics were reversible with physiological increases in VMB iron. The small changes in VMB iron induced by iron infusion likely represent biologically relevant changes in the non-transferrin-bound labile iron pool and may mimic circadian-dependent changes that have been found in VBM extracellular iron.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Iron deficiency; Microdialysis; Restless Legs Syndrome; Striatum; Ventral midbrain

Mesh:

Substances:

Year:  2014        PMID: 24999026      PMCID: PMC4318655          DOI: 10.1016/j.expneurol.2014.06.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

Review 1.  Clinical practice. Restless legs syndrome.

Authors:  Christopher J Earley
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

2.  Augmentation: understanding a key feature of RLS.

Authors:  Diego Garcia-Borreguero
Journal:  Sleep Med       Date:  2004-01       Impact factor: 3.492

3.  Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats.

Authors:  D Ben-Shachar; M B Youdim
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

4.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

Authors:  H Ohkawa; N Ohishi; K Yagi
Journal:  Anal Biochem       Date:  1979-06       Impact factor: 3.365

5.  New high performance liquid chromatographic analysis of brain catecholamines.

Authors:  C Refshauge; P T Kissinger; R Dreiling; L Blank; R Freeman; R N Adams
Journal:  Life Sci       Date:  1974-01-16       Impact factor: 5.037

Review 6.  Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain.

Authors:  I N Mefford
Journal:  J Neurosci Methods       Date:  1981-02       Impact factor: 2.390

7.  In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.

Authors:  R E See; B A Sorg; M A Chapman; P W Kalivas
Journal:  Neuropharmacology       Date:  1991-12       Impact factor: 5.250

Review 8.  Iron status and neural functioning.

Authors:  John L Beard; James R Connor
Journal:  Annu Rev Nutr       Date:  2003-04-10       Impact factor: 11.848

9.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

Authors:  J R Connor; S L Menzies; S M St Martin; E J Mufson
Journal:  J Neurosci Res       Date:  1992-01       Impact factor: 4.164

10.  Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma.

Authors:  Peter M Bungay; Paige Newton-Vinson; Wanda Isele; Paul A Garris; Joseph B Justice
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

View more
  18 in total

1.  Restless legs syndrome/Willis-Ekbom disease prevalence in beta thalassemia patients.

Authors:  Euthimia Dimitriadou; Christoforos D Giannaki; Maria Tsekoura; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Sleep Breath       Date:  2017-04-19       Impact factor: 2.816

Review 2.  A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.

Authors:  Chun Min Kho; Siti Kartini Enche Ab Rahim; Zainal Arifin Ahmad; Norazharuddin Shah Abdullah
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

3.  Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

Authors:  Gabriel Yepes; Xavier Guitart; William Rea; Amy H Newman; Richard P Allen; Christopher J Earley; César Quiroz; Sergi Ferré
Journal:  Ann Neurol       Date:  2017-12-07       Impact factor: 10.422

Review 4.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

5.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

Review 6.  Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.

Authors:  Farhan H Khan; Caitlyn D Ahlberg; Christopher A Chow; Divya R Shah; Brian B Koo
Journal:  J Neurol       Date:  2017-02-24       Impact factor: 4.849

Review 7.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

8.  Modeling relationships between iron status, behavior, and brain electrophysiology: evidence from a randomized study involving a biofortified grain in Indian adolescents.

Authors:  Michael J Wenger; Laura E Murray Kolb; Samuel P Scott; Erick Boy; Jere D Haas
Journal:  BMC Public Health       Date:  2022-07-06       Impact factor: 4.135

9.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

10.  Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla.

Authors:  Xu Li; Richard P Allen; Christopher J Earley; Hongjun Liu; Tiana E Cruz; Richard A E Edden; Peter B Barker; Peter C M van Zijl
Journal:  Sleep Med       Date:  2016-06-21       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.